speb/financial-data huggingface dataset:
Financial ratios for ACB.TO — annual report dated 2021-06-30
Total revenue: 234249193.5483871
Gross profit: -17385483.870967742
Operating income: -198907258.06451613
Net income: -559375000
Capital expenditures: 27291129.032258064
Operating cash flow: -169820161.29032257
Depreciation & amortization: 79093548.38709678
Net tangible assets: 631060483.8709677
Owner earnings: -507572580.6451613
Return on net tangible assets (%): -80.4316850156227
Buffett classification: The Gruesome
Stock price: 90.56451612903226
Shares outstanding: 61942146
Book value: 1643306451.6129034
P/B ratio: 3.413703192717279
Market cap (USD): 5609760480.4838705
Debt to equity: 0.19607891249938655
Current ratio: 5.721950590762621
Quick ratio: 4.538526315789474
Interest coverage ratio: -3.7124644399957853
COGS to revenue (%): 91.85489673596838
R&D to revenue (%): 3.9408680444384774
SG&A to revenue (%): 67.09080831345169
Free cash flow (dilution-adjusted): -228953225.80645162
Buyback yield (%): 0
Retained earnings: -3484745967.7419357
Inventory turnover: 1.9373225579250806
Receivables turnover: 5.142682624552955
Capitalized R&D asset: 9231451.612903226
ROCI (R&D-adjusted, %): -9.561300097114318
FCF margin (%): -97.73917354347623
Rule of 40 score: -97.73917354347623
Financial ratios for ACB.TO — annual report dated 2022-06-30
Total revenue: 196358914.72868216
Gross profit: 16453488.372093024
Operating income: -170058139.5348837
Net income: -1331491472.868217
Capital expenditures: 9740310.07751938
Operating cash flow: -85478294.5736434
Depreciation & amortization: 72604651.1627907
Net tangible assets: 458253488.372093
Owner earnings: -1268627131.7829456
Return on net tangible assets (%): -276.8396016557641
Buffett classification: The Gruesome
Stock price: 13.178294573643411
Shares outstanding: 61942146
Book value: 513452713.1782946
P/B ratio: 1.5898091987064318
Market cap (USD): 816291846.5116279
Debt to equity: 0.40686853253698174
Current ratio: 5.694162329871539
Quick ratio: 4.624865310988331
Interest coverage ratio: -3.054809017865846
COGS to revenue (%): 79.00182785043998
R&D to revenue (%): 4.101412142769726
SG&A to revenue (%): 74.61182852157297
Free cash flow (dilution-adjusted): -121113953.48837209
Buyback yield (%): 0
Retained earnings: -4680833333.333333
Inventory turnover: 1.4301518670716453
Receivables turnover: 5.383469353056193
Capitalized R&D asset: 14238560.952738184
ROCI (R&D-adjusted, %): -22.268333144667896
Rosenberg metric: 3.6656176798633138
FCF margin (%): -61.67988535469379
Revenue growth (%): -16.175201393757728
Rule of 40 score: -77.85508674845151
Financial ratios for ACB.TO — annual report dated 2024-03-31
Total revenue: 221614814.8148148
Gross profit: 97577037.03703703
Operating income: -23002222.22222222
Net income: -51352592.59259259
Capital expenditures: 3376296.296296296
Operating cash flow: -50746666.666666664
Depreciation & amortization: 24277777.777777776
Net tangible assets: 352402222.2222222
Owner earnings: -30451111.11111111
Return on net tangible assets (%): -8.641009957056646
Buffett classification: The Gruesome
Stock price: 4.360294117647058
Shares outstanding: 61942146
Book value: 445829629.6296296
P/B ratio: 0.6058053500450555
Market cap (USD): 270085974.83823526
Debt to equity: 0.17410902686626678
Current ratio: 3.4232466698764243
Quick ratio: 1.92769218424009
Interest coverage ratio: -2.2505435570372514
COGS to revenue (%): 46.09532722775587
R&D to revenue (%): 1.1939300755398088
SG&A to revenue (%): 52.12647904271675
Free cash flow (dilution-adjusted): -72636296.2962963
Buyback yield (%): 0
Retained earnings: -4716989629.629629
Inventory turnover: 0.7399450573035155
Receivables turnover: 6.588271564158464
Capitalized R&D asset: 11088142.167486317
ROCI (R&D-adjusted, %): -4.999834032936763
Rosenberg metric: 10.073094405407428
FCF margin (%): -32.77592085032422
Revenue growth (%): 12.862110243902011
Rule of 40 score: -19.91381060642221
Financial ratios for ACB.TO — quarterly report dated 2024-09-30
Operating income: -1771851.8518518517
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.8962962962962955
Shares outstanding: 61942146
Market cap (USD): 365229246.0444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACB.TO — quarterly report dated 2024-12-31
Total revenue: 67117482.51748252
Gross profit: 52403496.503496505
Operating income: 22765034.965034965
Net income: 19965734.265734266
Capital expenditures: 3149650.34965035
Operating cash flow: 20167132.86713287
Depreciation & amortization: 3797202.797202797
Net tangible assets: 339865734.26573426
Owner earnings: 20613286.713286713
Return on net tangible assets (%): 6.0651264999753085
Capex to operating income (%): 13.835473367328133
Buffett classification: The Great
Stock price: 4.272727272727273
P/E ratio: 3.313951455815909
Shares outstanding: 61942146
Book value: 428247552.44755244
P/B ratio: 0.6180114633063029
Market cap (USD): 264661896.5454546
Debt to equity: 0.16489547578846298
Current ratio: 3.298984693639149
Quick ratio: 1.6034230710180433
Effective tax rate (%): -1.3593913388382073
Interest coverage ratio: 16.474696356275302
COGS to revenue (%): 13.816707995582323
R&D to revenue (%): 0.9679301506595261
SG&A to revenue (%): 40.03104878201255
Free cash flow (dilution-adjusted): 15611188.811188811
Buyback yield (%): 0
Retained earnings: -4442705594.405595
Inventory turnover: 0.052207222635596656
Receivables turnover: 1.9383621124911645
Capitalized R&D asset: 649650.3496503497
ROCI (R&D-adjusted, %): 4.622539805074854
FCF margin (%): 23.259496968055178
Rule of 40 score: 23.259496968055178
Financial ratios for ACB.TO — quarterly report dated 2025-03-31
Total revenue: 68036363.63636364
Gross profit: 15315384.615384616
Operating income: -19756643.356643356
Net income: -15339160.83916084
Capital expenditures: 2803496.5034965035
Operating cash flow: 2574825.1748251747
Depreciation & amortization: 4162937.062937063
Net tangible assets: 334361538.4615385
Owner earnings: -13979720.279720278
Return on net tangible assets (%): -4.181019247621497
Buffett classification: The Gruesome
Stock price: 4.405594405594406
Shares outstanding: 61942146
Book value: 425588111.8881119
P/B ratio: 0.6412114536692131
Market cap (USD): 272891971.8881119
Debt to equity: 0.17184447354627327
Current ratio: 4.3145864715910625
Quick ratio: 2.1579336658759005
Interest coverage ratio: -10.84113584036838
COGS to revenue (%): 70.54742424865353
R&D to revenue (%): 0.8068494840274637
SG&A to revenue (%): 49.848908440570646
Free cash flow (dilution-adjusted): -2100000
Buyback yield (%): 0
Retained earnings: -4452968531.468532
Inventory turnover: 0.28707239442392707
Receivables turnover: 2.290840593360019
Capitalized R&D asset: 984216.7832167833
ROCI (R&D-adjusted, %): -3.7725968583801133
Rosenberg metric: -57.089343379978466
FCF margin (%): -3.086584714056654
Revenue growth (%): 1.3690637437746185
Rule of 40 score: -1.7175209702820355
Financial ratios for ACB.TO — annual report dated 2025-03-31
Total revenue: 223676923.07692307
Gross profit: 126539860.13986014
Operating income: 7296503.496503497
Net income: 1112587.4125874126
Capital expenditures: 9141958.041958041
Operating cash flow: 11193006.993006993
Depreciation & amortization: 8813986.013986014
Net tangible assets: 334361538.4615385
Owner earnings: 784615.384615384
Return on net tangible assets (%): 0.2346607771412794
Capex to operating income (%): 125.29231359018593
Buffett classification: The Gruesome
Stock price: 4.405594405594406
P/E ratio: 245.27688233815212
Shares outstanding: 61942146
Book value: 425588111.8881119
P/B ratio: 0.6412114536692131
Market cap (USD): 272891971.8881119
Debt to equity: 0.17184447354627327
Current ratio: 4.3145864715910625
Quick ratio: 2.1579336658759005
Effective tax rate (%): 13.56446716727912
Interest coverage ratio: 4.148707753479125
COGS to revenue (%): 33.75216502322906
R&D to revenue (%): 1.1492599841179525
SG&A to revenue (%): 50.15444353431835
Free cash flow (dilution-adjusted): -7393006.993006993
Buyback yield (%): 0
Retained earnings: -4452968531.468532
Inventory turnover: 0.4515355949358617
Receivables turnover: 7.531386861313869
Capitalized R&D asset: 7001050.903790439
ROCI (R&D-adjusted, %): 1.0354432495024202
Rosenberg metric: 10.946195741548488
FCF margin (%): -3.3052166899061457
Revenue growth (%): 0.9304920629207032
Rule of 40 score: -2.3747246269854427
Financial ratios for ACB.TO — quarterly report dated 2025-06-30
Total revenue: 76244525.54744525
Gross profit: 20402189.781021897
Operating income: -14760583.941605838
Net income: -11101459.854014598
Capital expenditures: 3674452.5547445253
Operating cash flow: 7387591.240875912
Depreciation & amortization: 4512408.759124087
Net tangible assets: 336594890.5109489
Owner earnings: -10263503.649635036
Return on net tangible assets (%): -3.0492155225693125
Buffett classification: The Gruesome
Stock price: 4.204379562043795
Shares outstanding: 61942146
Book value: 429696350.36496353
P/B ratio: 0.6060751794850887
Market cap (USD): 260428292.6715328
Debt to equity: 0.17263761202954384
Current ratio: 2.9658730917551073
Quick ratio: 1.510902890652389
Interest coverage ratio: -11.39267605633803
COGS to revenue (%): 67.0834330572974
R&D to revenue (%): 0.7936431956344837
SG&A to revenue (%): 43.338279641951075
Free cash flow (dilution-adjusted): 2110218.9781021895
Buyback yield (%): 0
Retained earnings: -4659907299.270073
Inventory turnover: 0.3069792300986143
Receivables turnover: 2.669025960752249
Capitalized R&D asset: 1187291.307232913
ROCI (R&D-adjusted, %): -2.9618033330862987
Rosenberg metric: 9.26640941001441
FCF margin (%): 2.7676990091426927
Revenue growth (%): 12.06437480249836
Rule of 40 score: 14.832073811641052
Financial ratios for ACB.TO — quarterly report dated 2025-09-30
Total revenue: 69274100.71942447
Gross profit: 23230935.251798563
Operating income: -13146043.165467627
Net income: -37031654.676258996
Capital expenditures: 4026618.7050359715
Operating cash flow: -29064028.77697842
Depreciation & amortization: 4485611.510791367
Net tangible assets: 339087769.7841727
Owner earnings: -36572661.8705036
Return on net tangible assets (%): -10.78560335389916
Buffett classification: The Gruesome
Stock price: 5.978417266187051
Shares outstanding: 61942146
Book value: 407985611.5107914
P/B ratio: 0.9076692527949216
Market cap (USD): 370315995.1510792
Debt to equity: 0.17692823135249514
Current ratio: 3.4149102452544393
Quick ratio: 1.6265509684488706
Interest coverage ratio: -8.223672367236723
COGS to revenue (%): 60.3119710045591
R&D to revenue (%): 0.9388208659168562
SG&A to revenue (%): 48.563209438057555
Free cash flow (dilution-adjusted): -37205755.39568345
Buyback yield (%): 0
Retained earnings: -4608599280.57554
Inventory turnover: 0.2616415274549026
Receivables turnover: 2.060405700346643
Capitalized R&D asset: 1236936.9160482958
ROCI (R&D-adjusted, %): -2.869348117489966
Rosenberg metric: 4.674766338919219
FCF margin (%): -53.70803086477448
Revenue growth (%): -9.142197132151137
Rule of 40 score: -62.85022799692562
Financial ratios for ACB.TO — quarterly report dated 2025-12-31
Total revenue: 72389051.0948905
Gross profit: 34029197.08029197
Operating income: 1594160.5839416056
Net income: 1328467.1532846715
Capital expenditures: 3940145.9854014595
Operating cash flow: 12406569.343065692
Depreciation & amortization: 4665693.430656934
Net tangible assets: 346756934.30656934
Owner earnings: 2054014.5985401464
Return on net tangible assets (%): 0.5923499706351029
Capex to operating income (%): 247.16117216117217
Buffett classification: The Gruesome
Stock price: 4.211678832116788
P/E ratio: 49.094255826923074
Shares outstanding: 61942146
Book value: 414471532.8467153
P/B ratio: 0.6294290547104219
Market cap (USD): 260880425.12408757
Debt to equity: 0.17786258466502064
Current ratio: 3.05503134957344
Quick ratio: 1.475149895501422
Interest coverage ratio: 1.037037037037037
COGS to revenue (%): 47.96769281961824
R&D to revenue (%): 1.313865669083319
SG&A to revenue (%): 40.403133917497705
Free cash flow (dilution-adjusted): 8444525.547445254
Buyback yield (%): 0
Retained earnings: -4674776642.335766
Inventory turnover: 0.20632807078417767
Receivables turnover: 2.2444439415199384
Capitalized R&D asset: 1586522.0290920548
ROCI (R&D-adjusted, %): 0.3925915839855262
Rosenberg metric: 16.60352205929849
FCF margin (%): 11.665473465560181
Revenue growth (%): 4.496558371912003
Rule of 40 score: 16.162031837472185
Financial ratios for AMDIND.NS — annual report dated 2022-03-31
Total revenue: 27217460.10813662
Gross profit: 8726902.281418964
Operating income: 2435118.0271660294
Net income: 1081089.278649611
Capital expenditures: 813411.5785309245
Operating cash flow: -2115481.9992087563
Depreciation & amortization: 1412343.3997098773
Net tangible assets: 18434036.66095213
Owner earnings: 1680021.0998285636
Return on net tangible assets (%): 9.113690781505637
Capex to operating income (%): 33.40337385935935
Buffett classification: The Good
Stock price: 0.5991032572860345
P/E ratio: 10.62156658497908
Shares outstanding: 19166749
Book value: 18478649.610971913
P/B ratio: 0.6214123866857545
Market cap (USD): 11482861.757483846
Debt to equity: 0.6162109737403263
Current ratio: 1.3907281204876942
Quick ratio: 0.7259802795681999
Effective tax rate (%): 22.845472598420752
Interest coverage ratio: 3.1716763998625903
COGS to revenue (%): 67.93638257667524
SG&A to revenue (%): 1.5681961335336017
Free cash flow (dilution-adjusted): -2929249.6373466966
Buyback yield (%): 0
Retained earnings: 7059105.894764605
Inventory turnover: 1.693920130281197
Receivables turnover: 2.9625599825453124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.79872114790251
FCF margin (%): -10.762391588739765
Rule of 40 score: -10.762391588739765
Financial ratios for AMDIND.NS — annual report dated 2023-03-31
Total revenue: 42059890.37758831
Gross profit: 12790572.472594397
Operating income: 4462253.349573691
Net income: 2339354.4457978075
Capital expenditures: 1887015.834348356
Operating cash flow: 1399805.1157125458
Depreciation & amortization: 1646747.8684531061
Net tangible assets: 19189598.051157128
Owner earnings: 2099086.4799025576
Return on net tangible assets (%): 10.938668305123688
Capex to operating income (%): 42.288406473573154
Buffett classification: The Good
Stock price: 0.5408038976857491
P/E ratio: 4.430902971451778
Shares outstanding: 19166749
Book value: 19221023.142509136
P/B ratio: 0.5392768370503774
Market cap (USD): 10365452.565164434
Debt to equity: 0.6526394034140957
Current ratio: 1.3647992148618078
Quick ratio: 0.73724856808577
Effective tax rate (%): 26.980777711878584
Interest coverage ratio: 4.441425713766139
COGS to revenue (%): 69.5896200447306
SG&A to revenue (%): 1.2012914708653082
Free cash flow (dilution-adjusted): -491412.9110840439
Buyback yield (%): 0
Retained earnings: 8684263.093788063
Inventory turnover: 2.2080227214881067
Receivables turnover: 3.5811391432313786
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.960313763180395
FCF margin (%): -1.168364697749888
Revenue growth (%): 54.53275291111592
Rule of 40 score: 53.364388213366034
Financial ratios for AMDIND.NS — annual report dated 2024-03-31
Total revenue: 32860271.01570932
Gross profit: 9535136.107446937
Operating income: 984458.5681736419
Net income: -200707.51888715674
Capital expenditures: 1583595.1552943997
Operating cash flow: 2926238.158052524
Depreciation & amortization: 1663664.707998561
Net tangible assets: 18700551.62489507
Owner earnings: -120637.96618299559
Return on net tangible assets (%): -0.6451037841172372
Capex to operating income (%): 160.85950252149973
Buffett classification: The Gruesome
Stock price: 0.7041746641074856
Shares outstanding: 19166749
Book value: 18721861.134428587
P/B ratio: 0.7209079771608626
Market cap (USD): 13496739.039107487
Debt to equity: 0.6677711476182668
Current ratio: 1.4496818024515965
Quick ratio: 0.8265049268710271
Interest coverage ratio: 0.7882966362911821
COGS to revenue (%): 70.98278312163485
SG&A to revenue (%): 1.465284878794315
Free cash flow (dilution-adjusted): 1228048.9267298237
Buyback yield (%): 0
Retained earnings: 8349214.534116801
Inventory turnover: 2.2740013818791454
Receivables turnover: 3.071993273542601
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.402413192116906
FCF margin (%): 3.737184413794815
Revenue growth (%): -21.87266604665481
Rule of 40 score: -18.135481632859996
Financial ratios for AMDIND.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 18951230.291447684
Buffett classification: The Gruesome
Stock price: 0.8438843764930722
Shares outstanding: 19166749
Book value: 18967654.08504539
P/B ratio: 0.8527422503986217
Market cap (USD): 16174520.029264215
Debt to equity: 0.5145575614683383
Current ratio: 1.7757807247152726
Quick ratio: 1.1313576396697311
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMDIND.NS — quarterly report dated 2024-12-31
Total revenue: 5234759.295955239
Gross profit: 2110152.6984497025
Operating income: -93239.3052803357
Net income: -197167.50203986478
Capital expenditures: 0
Depreciation & amortization: 436099.77852896607
Owner earnings: 238932.2764891013
Buffett classification: The Gruesome
Stock price: 0.6983331390604964
Shares outstanding: 19166749
Market cap (USD): 13384775.994754631
Interest coverage ratio: -0.43837343124897243
COGS to revenue (%): 59.68959451334922
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMDIND.NS — quarterly report dated 2025-03-31
Total revenue: 9607867.664250642
Gross profit: 3466273.088613514
Operating income: 235527.23871872807
Net income: 5003.507131166705
Capital expenditures: 0
Depreciation & amortization: 522480.7107785831
Net tangible assets: 18358346.972176757
Owner earnings: 527484.2179097498
Return on net tangible assets (%): 2.873266415049164
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5280662854475435
P/E ratio: 505.7109784799765
Shares outstanding: 19166749
Book value: 18369733.45803133
P/B ratio: 0.5509777249440893
Market cap (USD): 10121313.94853542
Debt to equity: 0.5252576292823927
Current ratio: 1.4751858597362104
Quick ratio: 0.833661512871448
Effective tax rate (%): 59.92509363295879
Interest coverage ratio: 0.7481247679168214
COGS to revenue (%): 63.92255587042514
Buyback yield (%): 0
Retained earnings: 8256160.860416179
Inventory turnover: 0.593267481477048
Receivables turnover: 1.0605920217214002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.096807244034304
Revenue growth (%): 83.53981761251926
Rule of 40 score: 83.53981761251926
Financial ratios for AMDIND.NS — annual report dated 2025-03-31
Total revenue: 32319932.19546411
Gross profit: 11389420.154313771
Operating income: 1039981.2953004441
Net income: 116799.15828851998
Capital expenditures: 1475274.7252747251
Operating cash flow: 4709632.920271218
Depreciation & amortization: 1863490.7645545942
Net tangible assets: 18358346.972176757
Owner earnings: 505015.1975683891
Return on net tangible assets (%): 2.7508751105629052
Capex to operating income (%): 141.8558902877698
Buffett classification: The Gruesome
Stock price: 0.5280662854475435
P/E ratio: 86.655709654461
Shares outstanding: 19166749
Book value: 18369733.45803133
P/B ratio: 0.5509777249440893
Market cap (USD): 10121313.94853542
Debt to equity: 0.5252576292823927
Current ratio: 1.4751858597362104
Quick ratio: 0.833661512871448
Effective tax rate (%): 21.829277834285268
Interest coverage ratio: 0.9235305109731538
COGS to revenue (%): 64.76038351369995
SG&A to revenue (%): 1.2985021234175647
Free cash flow (dilution-adjusted): 3234358.1949964925
Buyback yield (%): 0
Retained earnings: 8256160.860416179
Inventory turnover: 2.0218514934112384
Receivables turnover: 3.567728389581161
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.843002552702222
FCF margin (%): 10.007317389887389
Revenue growth (%): -1.6443529025883368
Rule of 40 score: 8.362964487299053
Financial ratios for AMDIND.NS — quarterly report dated 2025-06-30
Total revenue: 10141387.783758484
Gross profit: 3384097.8235431784
Operating income: 477603.557219752
Net income: 177006.7868008425
Capital expenditures: 0
Depreciation & amortization: 476070.67633980815
Owner earnings: 653077.4631406507
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.5819096653405101
P/E ratio: 15.752667874826468
Shares outstanding: 19166749
Market cap (USD): 11153316.496255558
Effective tax rate (%): 26.489454757508017
Interest coverage ratio: 1.5633522292017774
COGS to revenue (%): 66.63082118836992
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.552950333537439
Rule of 40 score: 5.552950333537439
Financial ratios for AMDIND.NS — quarterly report dated 2025-09-30
Total revenue: 6647542.277339346
Gross profit: 2047046.2232243516
Operating income: -276347.237880496
Net income: -332130.77790304396
Capital expenditures: 0
Depreciation & amortization: 390755.3551296505
Net tangible assets: 17551195.03945885
Owner earnings: 58624.57722660655
Buffett classification: The Gruesome
Stock price: 0.617587373167982
Shares outstanding: 19166749
Book value: 17557643.742953777
P/B ratio: 0.6741873989686411
Market cap (USD): 11837142.167080045
Debt to equity: 0.5342421773215364
Current ratio: 1.8021699607204387
Quick ratio: 1.0161587104289251
Interest coverage ratio: -1.1769337878715127
COGS to revenue (%): 69.20596909624057
Buyback yield (%): 0
Inventory turnover: 0.6338917333598449
Receivables turnover: 0.9395632324938453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3655854853059723
Revenue growth (%): -34.45135499122281
Rule of 40 score: -34.45135499122281
Financial ratios for AMDIND.NS — quarterly report dated 2025-12-31
Total revenue: 4231257.65846051
Gross profit: 1639946.5300211653
Operating income: -630110.2818313468
Net income: -464085.99754929263
Capital expenditures: 0
Depreciation & amortization: 403832.01514982735
Owner earnings: -60253.98239946528
Buffett classification: The Gruesome
Stock price: 0.534365600980283
Shares outstanding: 19166749
Market cap (USD): 10242051.348223237
Interest coverage ratio: -3.3348072161301734
COGS to revenue (%): 61.242101937657964
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -36.34854083012985
Rule of 40 score: -36.34854083012985
Financial ratios for BNG.TO — annual report dated 2022-03-31
Total revenue: 6120000
Gross profit: 4899200
Operating income: 173600
Net income: -299200
Capital expenditures: 2472800
Operating cash flow: 668000
Depreciation & amortization: 853600
Net tangible assets: 33535200
Owner earnings: -1918400
Return on net tangible assets (%): -5.720556310980701
Capex to operating income (%): 1424.4239631336407
Buffett classification: The Gruesome
Stock price: 0.096
Shares outstanding: 485304215
Book value: 33535200
P/B ratio: 1.3892627639018107
Market cap (USD): 46589204.64
Debt to equity: 0.0016221761015291396
Current ratio: 2.6838054187192117
Quick ratio: 2.6838054187192117
Interest coverage ratio: 15.5
COGS to revenue (%): 19.947712418300654
SG&A to revenue (%): 36.431372549019606
Free cash flow (dilution-adjusted): -1912800
Buyback yield (%): 0
Retained earnings: -67051200
Receivables turnover: 2.891156462585034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.4787222308014737
FCF margin (%): -31.254901960784316
Rule of 40 score: -31.254901960784316
Financial ratios for BNG.TO — annual report dated 2023-03-31
Total revenue: 6036296.296296296
Gross profit: 4800740.740740741
Operating income: 328888.8888888889
Net income: 520740.74074074073
Capital expenditures: 4065185.1851851847
Operating cash flow: 1563703.7037037036
Depreciation & amortization: 794074.074074074
Net tangible assets: 30765925.925925925
Owner earnings: -2750370.37037037
Return on net tangible assets (%): -8.939663889825201
Capex to operating income (%): 1236.036036036036
Buffett classification: The Gruesome
Stock price: 0.04444444444444444
P/E ratio: 41.419989900426735
Shares outstanding: 485304215
Book value: 30765925.925925925
P/B ratio: 0.701070277363124
Market cap (USD): 21569076.22222222
Debt to equity: 0.000770453122742813
Current ratio: 0.9074013694163678
Quick ratio: 0.9074013694163678
Interest coverage ratio: 148
COGS to revenue (%): 20.468769174131797
SG&A to revenue (%): 34.01644373542766
Free cash flow (dilution-adjusted): -2561481.4814814813
Buyback yield (%): 0
Retained earnings: -61563703.7037037
Receivables turnover: 7.510599078341013
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9521767102723568
FCF margin (%): -42.43465455884158
Revenue growth (%): -1.3677075768579132
Rule of 40 score: -43.80236213569949
Financial ratios for BNG.TO — annual report dated 2024-03-31
Total revenue: 5209629.62962963
Gross profit: 3882222.222222222
Operating income: -817777.7777777778
Net income: -9428148.148148147
Capital expenditures: 0
Operating cash flow: -202222.22222222222
Depreciation & amortization: 918518.5185185184
Net tangible assets: 20522962.962962963
Owner earnings: -8509629.629629629
Return on net tangible assets (%): -41.463942828268245
Buffett classification: The Gruesome
Stock price: 0.014705882352941176
Shares outstanding: 485304215
Book value: 20522962.96296296
P/B ratio: 0.34774835895070516
Market cap (USD): 7136826.69117647
Debt to equity: 0
Current ratio: 1.0626179987413469
Quick ratio: 1.0626179987413469
Interest coverage ratio: -64.94117647058825
COGS to revenue (%): 25.479880563059858
SG&A to revenue (%): 43.551827100810456
Free cash flow (dilution-adjusted): -517777.77777777775
Buyback yield (%): 0
Retained earnings: -70991851.85185185
Receivables turnover: 3.94668911335578
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5403905974409136
FCF margin (%): -9.938859661595336
Revenue growth (%): -13.694931893483856
Rule of 40 score: -23.633791555079192
Financial ratios for BNG.TO — quarterly report dated 2024-09-30
Capital expenditures: 6666.666666666666
Buffett classification: The Gruesome
Stock price: 0.014814814814814814
Shares outstanding: 485304215
Market cap (USD): 7189692.074074074
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNG.TO — quarterly report dated 2024-12-31
Total revenue: 1000699.3006993007
Gross profit: 748251.7482517483
Operating income: -181118.88111888114
Net income: -258741.25874125876
Capital expenditures: 76923.07692307692
Operating cash flow: 208391.6083916084
Depreciation & amortization: 192307.6923076923
Net tangible assets: 18776923.076923076
Owner earnings: -143356.64335664338
Return on net tangible assets (%): -0.7634724963688505
Buffett classification: The Gruesome
Stock price: 0.006993006993006994
Shares outstanding: 485304215
Book value: 18776923.07692308
P/B ratio: 0.18073971732896355
Market cap (USD): 3393735.7692307695
Debt to equity: 0.06230680421585788
Current ratio: 1.402777777777778
Quick ratio: 1.402777777777778
Interest coverage ratio: -3.011627906976744
COGS to revenue (%): 25.227113906359193
SG&A to revenue (%): 45.492662473794546
Free cash flow (dilution-adjusted): 195104.8951048951
Buyback yield (%): 0
Retained earnings: -67851048.95104896
Receivables turnover: 0.7571428571428571
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8306074017061125
FCF margin (%): 19.49685534591195
Rule of 40 score: 19.49685534591195
Financial ratios for BNG.TO — quarterly report dated 2025-03-31
Total revenue: 680419.5804195805
Gross profit: 655244.7552447553
Operating income: -299300.6993006993
Net income: -2093006.993006993
Capital expenditures: 0
Operating cash flow: -188811.18881118883
Depreciation & amortization: 0
Net tangible assets: 16808391.60839161
Owner earnings: -2093006.993006993
Return on net tangible assets (%): -12.45215510068231
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 485304215
Book value: 16808391.60839161
P/B ratio: 0.403814457480446
Market cap (USD): 6787471.538461539
Debt to equity: 0.07072724246962889
Current ratio: 1.8784838350055741
Quick ratio: 1.8784838350055741
Interest coverage ratio: -17.833333333333332
COGS to revenue (%): 3.6998972250770814
SG&A to revenue (%): 56.62898252826311
Free cash flow (dilution-adjusted): -192307.6923076923
Buyback yield (%): 0
Retained earnings: -69944055.94405594
Receivables turnover: 0.5784780023781213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4839984743940915
FCF margin (%): -28.263103802672145
Revenue growth (%): -32.005590496156536
Rule of 40 score: -60.26869429882868
Financial ratios for BNG.TO — annual report dated 2025-03-31
Total revenue: 3886713.286713287
Gross profit: 2964335.6643356644
Operating income: -999300.6993006994
Net income: -2923776.223776224
Capital expenditures: 134965.03496503498
Operating cash flow: -274125.87412587414
Depreciation & amortization: 616083.9160839161
Net tangible assets: 16808391.60839161
Owner earnings: -2442657.342657343
Return on net tangible assets (%): -14.532368114494925
Buffett classification: The Gruesome
Stock price: 0.013986013986013988
Shares outstanding: 485304215
Book value: 16808391.60839161
P/B ratio: 0.403814457480446
Market cap (USD): 6787471.538461539
Debt to equity: 0.07072724246962889
Current ratio: 1.8784838350055741
Quick ratio: 1.8784838350055741
Interest coverage ratio: -12.213675213675215
COGS to revenue (%): 23.731558114429653
SG&A to revenue (%): 48.99244332493703
Free cash flow (dilution-adjusted): -323076.92307692306
Buyback yield (%): 0
Retained earnings: -69944055.94405594
Receivables turnover: 3.3043995243757434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.954751915675601
FCF margin (%): -8.312342569269521
Revenue growth (%): -25.393673580791454
Rule of 40 score: -33.706016150060975
Financial ratios for BNG.TO — quarterly report dated 2025-06-30
Total revenue: 761313.8686131387
Gross profit: 503649.63503649633
Operating income: -135036.49635036496
Net income: -188321.16788321166
Capital expenditures: 43795.620437956204
Operating cash flow: 205109.48905109486
Depreciation & amortization: 183941.60583941604
Net tangible assets: 17270802.91970803
Owner earnings: -48175.18248175183
Return on net tangible assets (%): -0.27894002789400285
Buffett classification: The Gruesome
Stock price: 0.0072992700729927005
Shares outstanding: 485304215
Book value: 17270802.91970803
P/B ratio: 0.20510722919572294
Market cap (USD): 3542366.5328467153
Debt to equity: 0.07184818900300072
Current ratio: 1.9452991452991453
Quick ratio: 1.9452991452991453
Interest coverage ratio: -3.557692307692308
COGS to revenue (%): 33.84467881112177
SG&A to revenue (%): 47.17162032598274
Free cash flow (dilution-adjusted): 201459.8540145985
Buyback yield (%): 0
Retained earnings: -73195620.4379562
Receivables turnover: 0.6522826766729206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.64937344238127
FCF margin (%): 26.46212847555129
Revenue growth (%): 11.888883054140623
Rule of 40 score: 38.35101152969191
Financial ratios for BNG.TO — quarterly report dated 2025-09-30
Total revenue: 680575.5395683454
Gross profit: 461870.5035971223
Operating income: -444604.3165467626
Net income: -487769.7841726619
Capital expenditures: 0
Operating cash flow: -374100.71942446043
Depreciation & amortization: 176258.9928057554
Net tangible assets: 17043165.4676259
Owner earnings: -311510.7913669065
Return on net tangible assets (%): -1.8277754326720135
Buffett classification: The Gruesome
Stock price: 0.014388489208633094
Shares outstanding: 485304215
Book value: 17043165.4676259
P/B ratio: 0.40971229632756434
Market cap (USD): 6982794.460431655
Debt to equity: 0.07176023638666103
Current ratio: 1.5906515580736544
Quick ratio: 1.5906515580736544
Interest coverage ratio: -13.733333333333333
COGS to revenue (%): 32.1353065539112
SG&A to revenue (%): 52.959830866807614
Free cash flow (dilution-adjusted): -417266.18705035973
Buyback yield (%): 0
Retained earnings: -72630215.82733813
Receivables turnover: 0.5607587433313574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1579719254137855
FCF margin (%): -61.31078224101479
Revenue growth (%): -10.605130468970927
Rule of 40 score: -71.91591270998572
Financial ratios for BNG.TO — quarterly report dated 2025-12-31
Total revenue: 738686.1313868612
Gross profit: 459854.0145985401
Operating income: -270072.9927007299
Net income: -302919.70802919706
Capital expenditures: 0
Operating cash flow: -302919.70802919706
Depreciation & amortization: 184671.5328467153
Net tangible assets: 16917518.24817518
Owner earnings: -118248.17518248176
Return on net tangible assets (%): -0.6989688052810977
Buffett classification: The Gruesome
Stock price: 0.014598540145985401
Shares outstanding: 485304215
Book value: 16917518.24817518
P/B ratio: 0.4187808732795444
Market cap (USD): 7084733.065693431
Debt to equity: 0.07334857833196703
Current ratio: 1.5820271682340648
Quick ratio: 1.5820271682340648
Interest coverage ratio: -8.222222222222223
COGS to revenue (%): 37.74703557312253
SG&A to revenue (%): 38.04347826086957
Free cash flow (dilution-adjusted): -308029.1970802919
Buyback yield (%): 0
Retained earnings: -73993430.6569343
Receivables turnover: 0.5521003818876159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3146207141588204
FCF margin (%): -41.699604743083
Revenue growth (%): 8.538448480733292
Rule of 40 score: -33.16115626234971
Financial ratios for BVZN.SW — annual report dated 2021-12-31
Operating income: 7142719.78021978
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 711.6593406593406
Shares outstanding: 197278
Market cap (USD): 140394731.4065934
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BVZN.SW — annual report dated 2022-12-31
Total revenue: 150045115.2173913
Gross profit: 18829294.56521739
Operating income: 29794233.695652172
Net income: 25581919.56521739
Capital expenditures: 129670598.91304347
Operating cash flow: 68320021.73913044
Depreciation & amortization: 25393435.869565215
Net tangible assets: 206236960.86956522
Owner earnings: -78695243.47826086
Return on net tangible assets (%): -38.157681894872255
Capex to operating income (%): 435.22045318442315
Buffett classification: The Gruesome
Stock price: 737.25
P/E ratio: 5.685390618527029
Shares outstanding: 197278
Book value: 226620552.173913
P/B ratio: 0.6417917708910358
Market cap (USD): 145443205.5
Debt to equity: 1.486561840864543
Current ratio: 1.5783805426834772
Quick ratio: 1.3574052982866356
Effective tax rate (%): 8.913186928442524
Interest coverage ratio: 8.151867432167387
COGS to revenue (%): 87.45091132228012
SG&A to revenue (%): 8.130257576297376
Free cash flow (dilution-adjusted): -62261227.17391304
Buyback yield (%): 0
Retained earnings: 148269293.47826087
Inventory turnover: 10.12948858476378
Receivables turnover: 23.819528832634955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.365824063960474
FCF margin (%): -41.4950044083118
Rule of 40 score: -41.4950044083118
Financial ratios for BVZN.SW — annual report dated 2023-12-31
Total revenue: 199255609.52380952
Gross profit: 37435971.42857143
Operating income: 43938104.76190476
Net income: 35188427.38095238
Capital expenditures: 174313684.52380952
Operating cash flow: 73143072.61904763
Depreciation & amortization: 36470997.61904762
Net tangible assets: 253214823.80952382
Owner earnings: -102654259.52380952
Return on net tangible assets (%): -40.540383054757214
Capex to operating income (%): 396.72554259769316
Buffett classification: The Gruesome
Stock price: 1036.0119047619048
P/E ratio: 5.808226503985567
Shares outstanding: 197278
Book value: 279857120.23809516
P/B ratio: 0.7303096536323102
Market cap (USD): 204382356.54761904
Debt to equity: 1.764233135615236
Current ratio: 1.8010554080473857
Quick ratio: 1.574457522066354
Effective tax rate (%): 11.924491294841083
Interest coverage ratio: 6.972721227234943
COGS to revenue (%): 81.21208656657764
SG&A to revenue (%): 8.013771518842105
Free cash flow (dilution-adjusted): -103092229.76190476
Buyback yield (%): 0
Retained earnings: 190120008.33333334
Inventory turnover: 10.498888965354828
Receivables turnover: 16.976753446806704
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.803998807749327
FCF margin (%): -51.73868379830282
Revenue growth (%): 32.797131872717145
Rule of 40 score: -18.941551925585678
Financial ratios for BVZN.SW — annual report dated 2024-12-31
Total revenue: 188208022.2222222
Gross profit: 33534724.444444444
Operating income: 35455635.55555555
Net income: 25512435.555555556
Capital expenditures: 32769280
Operating cash flow: 69887465.55555555
Depreciation & amortization: 37828782.222222224
Net tangible assets: 257680208.8888889
Owner earnings: 30571937.777777776
Return on net tangible assets (%): 11.864294083586499
Capex to operating income (%): 92.42333267063768
Buffett classification: The Gruesome
Stock price: 955.6666666666666
P/E ratio: 7.389808325282067
Shares outstanding: 197278
Book value: 283317491.11111116
P/B ratio: 0.6654442968815094
Market cap (USD): 188532008.66666666
Debt to equity: 1.5678490054553713
Current ratio: 1.8799062141286706
Quick ratio: 1.6507970436944694
Effective tax rate (%): 16.84589080498379
Interest coverage ratio: 4.8643728707936456
COGS to revenue (%): 82.18209614633264
SG&A to revenue (%): 7.89888221791467
Free cash flow (dilution-adjusted): 36760067.777777776
Buyback yield (%): 0
Retained earnings: 198037216.66666666
Inventory turnover: 9.782725150800005
Receivables turnover: 12.455725709226572
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9995826196155395
FCF margin (%): 19.53161578541758
Revenue growth (%): -5.544429754318767
Rule of 40 score: 13.987186031098812
Financial ratios for BVZN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 257680208.8888889
Buffett classification: The Gruesome
Stock price: 955.6666666666666
Shares outstanding: 197278
Book value: 283317491.11111116
P/B ratio: 0.6654442968815094
Market cap (USD): 188532008.66666666
Debt to equity: 1.5678490054553713
Current ratio: 1.8799062141286706
Quick ratio: 1.6507970436944694
Buyback yield (%): 0
Retained earnings: 198037216.66666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BVZN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 299739355
Buffett classification: The Gruesome
Stock price: 1200.3374999999999
Shares outstanding: 197278
Book value: 329511406.25
P/B ratio: 0.71864031664306
Market cap (USD): 236800181.32499996
Debt to equity: 1.4752281735315498
Current ratio: 1.8470661905576171
Quick ratio: 1.632642338717961
Buyback yield (%): 0
Retained earnings: 231964851.25
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBUS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 106.5
Shares outstanding: 76331634
Market cap (USD): 8129319021
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBUS — annual report dated 2022-12-31
Total revenue: 157000
Gross profit: 157000
Operating income: -22370000
Net income: -16891000
Capital expenditures: 1520000
Operating cash flow: -19364000
Depreciation & amortization: 1534000
Net tangible assets: 7075000
Owner earnings: -16877000
Return on net tangible assets (%): -238.5441696113074
Buffett classification: The Gruesome
Stock price: 7.4
Shares outstanding: 76331634
Book value: 7233000
P/B ratio: 78.09402621318955
Market cap (USD): 564854091.6
Debt to equity: 1.92326835338034
Current ratio: 2.4861612515042117
Quick ratio: 2.4861612515042117
Interest coverage ratio: -257.1264367816092
COGS to revenue (%): 0
R&D to revenue (%): 7358.59872611465
SG&A to revenue (%): 6989.808917197452
Free cash flow (dilution-adjusted): -24882000
Buyback yield (%): 0
Retained earnings: -212151000
Capitalized R&D asset: 11553000
ROCI (R&D-adjusted, %): -45.39489972765536
FCF margin (%): -15848.407643312103
Rule of 40 score: -15848.407643312103
Financial ratios for CBUS — annual report dated 2023-12-31
Total revenue: 1817000
Gross profit: 1817000
Operating income: -69464000
Net income: -267627000
Capital expenditures: 4321000
Operating cash flow: -46210000
Depreciation & amortization: 4693000
Net tangible assets: -176839000
Owner earnings: -267255000
Buffett classification: The Gruesome
Stock price: 19.64
Shares outstanding: 76331634
Book value: 338294000
P/B ratio: 4.431510141356335
Market cap (USD): 1499153291.76
Debt to equity: 0.07277988968175611
Current ratio: 1.6517375603808095
Quick ratio: 1.6517375603808095
Interest coverage ratio: -3.6769002752487827
COGS to revenue (%): 0
R&D to revenue (%): 2331.7006053935056
SG&A to revenue (%): 1591.304347826087
Free cash flow (dilution-adjusted): -66623000
Buyback yield (%): 0
Retained earnings: -479778000
Receivables turnover: 3.4283018867924526
Capitalized R&D asset: 50107510
ROCI (R&D-adjusted, %): -7.862994832833447
Rosenberg metric: 0.1436856227819614
FCF margin (%): -3666.6483214089153
Revenue growth (%): 1057.3248407643312
Rule of 40 score: -2609.3234806445844
Financial ratios for CBUS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.26
Shares outstanding: 76331634
Market cap (USD): 248841126.83999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBUS — annual report dated 2024-12-31
Total revenue: 4262000
Gross profit: 4262000
Operating income: -76964000
Net income: -251388000
Capital expenditures: 808000
Operating cash flow: -58043000
Depreciation & amortization: 6859000
Net tangible assets: -194887000
Owner earnings: -245337000
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 76331634
Book value: 97831000
P/B ratio: 2.1690664770880392
Market cap (USD): 212201942.51999998
Debt to equity: 0.37090492788584395
Current ratio: 0.8525002515343596
Quick ratio: 0.8525002515343596
Interest coverage ratio: -2.2510675636150923
COGS to revenue (%): 0
R&D to revenue (%): 1183.2238385734397
SG&A to revenue (%): 722.5950258094791
Free cash flow (dilution-adjusted): -69601000
Buyback yield (%): 0
Retained earnings: -731166000
Receivables turnover: 4.094140249759846
Capitalized R&D asset: 82627380
ROCI (R&D-adjusted, %): -14.853505311464088
Rosenberg metric: 0.057710010149408734
FCF margin (%): -1633.0595964335992
Revenue growth (%): 134.5624656026417
Rule of 40 score: -1498.4971308309575
Financial ratios for CBUS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.78
Shares outstanding: 76331634
Market cap (USD): 212201942.51999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBUS — quarterly report dated 2025-03-31
Total revenue: 1034000
Operating income: -20621000
Net income: -46886000
Capital expenditures: 291000
Operating cash flow: -11827000
Depreciation & amortization: 1634000
Net tangible assets: -195285000
Owner earnings: -45543000
Buffett classification: The Gruesome
Stock price: 1.87
Shares outstanding: 76331634
Book value: 73957000
P/B ratio: 1.9300425325526998
Market cap (USD): 142740155.58
Debt to equity: 0.4819692524034236
Current ratio: 1.2317502617302751
Quick ratio: 1.2317502617302751
Interest coverage ratio: -2.461621105407664
COGS to revenue (%): 0
R&D to revenue (%): 1141.10251450677
SG&A to revenue (%): 953.1914893617021
Free cash flow (dilution-adjusted): -14617000
Buyback yield (%): 0
Retained earnings: -778052000
Receivables turnover: 1.088421052631579
Capitalized R&D asset: 11799000
ROCI (R&D-adjusted, %): -3.914618052358592
FCF margin (%): -1413.6363636363637
Rule of 40 score: -1413.6363636363637
Financial ratios for CBUS — quarterly report dated 2025-06-30
Total revenue: 933000
Operating income: -17946000
Net income: -25372000
Capital expenditures: 93000
Operating cash flow: -13604000
Depreciation & amortization: 1575000
Net tangible assets: -192982000
Owner earnings: -23890000
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 76331634
Book value: 74476000
P/B ratio: 1.4143838944089369
Market cap (USD): 105337654.91999999
Debt to equity: 0.4756028787797411
Current ratio: 1.7767024929759623
Quick ratio: 1.7767024929759623
Interest coverage ratio: -2.0703737886479003
COGS to revenue (%): 0
R&D to revenue (%): 1310.6109324758843
SG&A to revenue (%): 712.8617363344051
Free cash flow (dilution-adjusted): -15675000
Buyback yield (%): 0
Retained earnings: -803424000
Receivables turnover: 0.9790136411332634
Capitalized R&D asset: 20133330
ROCI (R&D-adjusted, %): -3.9914706340494863
FCF margin (%): -1680.064308681672
Revenue growth (%): -9.767891682785299
Rule of 40 score: -1689.8322003644573
Financial ratios for CBUS — quarterly report dated 2025-09-30
Total revenue: 615000
Operating income: -15438000
Net income: -23541000
Capital expenditures: 108000
Operating cash flow: -11740000
Depreciation & amortization: 1420000
Net tangible assets: -214249000
Owner earnings: -22229000
Buffett classification: The Gruesome
Stock price: 1.29
Shares outstanding: 76331634
Book value: 52029000
P/B ratio: 1.8925562255665112
Market cap (USD): 98467807.86
Debt to equity: 0.6525014895539026
Current ratio: 1.276423950581254
Quick ratio: 1.276423950581254
Interest coverage ratio: -1.7096345514950166
COGS to revenue (%): 0
R&D to revenue (%): 1753.4959349593496
SG&A to revenue (%): 856.7479674796749
Free cash flow (dilution-adjusted): -13734000
Buyback yield (%): 0
Retained earnings: -826965000
Receivables turnover: 1.0182119205298013
Capitalized R&D asset: 22870430
ROCI (R&D-adjusted, %): -4.888973450798205
FCF margin (%): -2233.170731707317
Revenue growth (%): -34.08360128617363
Rule of 40 score: -2267.2543329934906
Financial ratios for CBUS — quarterly report dated 2025-12-31
Total revenue: 1057000
Operating income: -13459000
Net income: -31286000
Capital expenditures: 86000
Operating cash flow: -13420000
Depreciation & amortization: 1294000
Net tangible assets: -242366000
Owner earnings: -30078000
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 76331634
Book value: 21829000
P/B ratio: 6.084430947821706
Market cap (USD): 132817043.16
Debt to equity: 1.5136744697420863
Current ratio: 0.7159212243445249
Quick ratio: 0.7159212243445249
Interest coverage ratio: -1.4308951732936424
COGS to revenue (%): 0
R&D to revenue (%): 888.0794701986755
SG&A to revenue (%): 485.2412488174077
Free cash flow (dilution-adjusted): -15331000
Buyback yield (%): 0
Retained earnings: -858251000
Receivables turnover: 2.1013916500994037
Capitalized R&D asset: 20647520
ROCI (R&D-adjusted, %): -4.815384743574583
FCF margin (%): -1450.4257332071902
Revenue growth (%): 71.869918699187
Rule of 40 score: -1378.555814508003
Financial ratios for CBUS — annual report dated 2025-12-31
Total revenue: 3639000
Gross profit: 3639000
Operating income: -67464000
Net income: -127085000
Capital expenditures: 578000
Operating cash flow: -50591000
Depreciation & amortization: 5923000
Net tangible assets: -242366000
Owner earnings: -121740000
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 76331634
Book value: 21829000
P/B ratio: 6.084430947821706
Market cap (USD): 132817043.16
Debt to equity: 1.5136744697420863
Current ratio: 0.7159212243445249
Quick ratio: 0.7159212243445249
Interest coverage ratio: -1.9014120233364336
COGS to revenue (%): 0
R&D to revenue (%): 1214.5644407804343
SG&A to revenue (%): 739.3514701841166
Free cash flow (dilution-adjusted): -59357000
Buyback yield (%): 0
Retained earnings: -858251000
Receivables turnover: 7.2345924453280315
Capitalized R&D asset: 91966540
ROCI (R&D-adjusted, %): -18.132227315868306
Rosenberg metric: -0.012354002657201213
FCF margin (%): -1631.134927177796
Revenue growth (%): -14.617550445800093
Rule of 40 score: -1645.7524776235962
Financial ratios for CDSL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.269286562046684
Shares outstanding: 209000000
Market cap (USD): 1937280891.467757
Buyback yield (%): 0
Retained earnings: 129049334.03666095
Capitalized R&D asset: 0
Rule of 40 score: 0